AU2193177A - Beta-lactam containing compounds - Google Patents
Beta-lactam containing compoundsInfo
- Publication number
- AU2193177A AU2193177A AU21931/77A AU2193177A AU2193177A AU 2193177 A AU2193177 A AU 2193177A AU 21931/77 A AU21931/77 A AU 21931/77A AU 2193177 A AU2193177 A AU 2193177A AU 2193177 A AU2193177 A AU 2193177A
- Authority
- AU
- Australia
- Prior art keywords
- beta
- containing compounds
- lactam containing
- lactam
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003952 β-lactams Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4320/76A GB1529913A (en) | 1976-02-04 | 1976-02-04 | Beta-lactam compounds |
| GB859776 | 1976-03-04 | ||
| GB1534676 | 1976-04-14 | ||
| GB2422776 | 1976-06-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2193177A true AU2193177A (en) | 1978-08-10 |
| AU506250B2 AU506250B2 (en) | 1979-12-20 |
Family
ID=27447370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21931/77A Expired AU506250B2 (en) | 1976-02-04 | 1977-02-03 | Clavulanic acid derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4206120A (en) |
| JP (1) | JPS5297994A (en) |
| AT (1) | AT352875B (en) |
| AU (1) | AU506250B2 (en) |
| BE (1) | BE850942A (en) |
| CH (1) | CH636357A5 (en) |
| DE (1) | DE2704104A1 (en) |
| DK (1) | DK46677A (en) |
| ES (1) | ES455625A1 (en) |
| FR (1) | FR2340321A1 (en) |
| GB (1) | GB1529913A (en) |
| IE (1) | IE44460B1 (en) |
| IL (1) | IL51339A (en) |
| NL (1) | NL7701191A (en) |
| SE (1) | SE7701216L (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1136132A (en) * | 1975-02-17 | 1982-11-23 | Teruji Tsuji | Cyclization to form cephem ring and intermediates therefor |
| GB1593275A (en) * | 1976-10-22 | 1981-07-15 | Glaxo Lab Ltd | Clavam derivatives |
| EP0000615B1 (en) * | 1977-07-23 | 1981-04-29 | Beecham Group Plc | Beta-lactam compounds, preparation and use in pharmaceutical compositions and as chemical intermediates |
| DE2861335D1 (en) * | 1977-11-29 | 1982-01-21 | Beecham Group Plc | Clavulanic acid derivatives, a process for their preparation and compositions containing them |
| NZ189022A (en) * | 1977-12-08 | 1981-11-19 | Beecham Group Ltd | Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder |
| EP0024372A1 (en) * | 1979-08-03 | 1981-03-04 | Beecham Group Plc | Derivatives of clavulanic acid, their preparation and pharmaceutical compositions containing them |
| EP0025287A1 (en) * | 1979-08-21 | 1981-03-18 | Beecham Group Plc | Clavulanic acid derivatives, their preparation, pharmaceutical compositions containing them and their preparation |
| US4562182A (en) * | 1980-12-23 | 1985-12-31 | Beecham Group P.L.C. | Compounds containing beta-lactams |
| EP0057664A3 (en) * | 1981-01-30 | 1982-11-17 | Ciba-Geigy Ag | Clavam derivatives |
| DE3725375A1 (en) * | 1987-07-31 | 1989-02-09 | Bayer Ag | STABLE OXAPENEM-3-CARBONSAEURES |
| GB9421816D0 (en) * | 1994-10-29 | 1994-12-14 | Smithkline Beecham Plc | Novel compounds |
| FR2739851B1 (en) | 1995-10-13 | 1997-11-21 | Oreal | NOVEL ALKYL-3-OXO-ALKANOATES DERIVATIVES AND THEIR PREPARATION PROCESS |
| US5767316A (en) | 1995-11-17 | 1998-06-16 | Ajinomoto Co., Inc. | Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
| EP2477993B1 (en) | 2009-09-15 | 2015-06-24 | Nabriva Therapeutics AG | Substituted clavulanic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1542405A (en) * | 1975-04-15 | 1979-03-21 | Beecham Group Ltd | Clavulanic acid derivatives |
-
1976
- 1976-02-04 GB GB4320/76A patent/GB1529913A/en not_active Expired
-
1977
- 1977-01-26 IL IL51339A patent/IL51339A/en unknown
- 1977-01-31 US US05/763,866 patent/US4206120A/en not_active Expired - Lifetime
- 1977-01-31 BE BE174540A patent/BE850942A/en unknown
- 1977-02-01 DE DE19772704104 patent/DE2704104A1/en not_active Withdrawn
- 1977-02-02 FR FR7702856A patent/FR2340321A1/en active Granted
- 1977-02-02 AT AT65177A patent/AT352875B/en not_active IP Right Cessation
- 1977-02-03 DK DK46677A patent/DK46677A/en not_active Application Discontinuation
- 1977-02-03 SE SE7701216A patent/SE7701216L/en not_active Application Discontinuation
- 1977-02-03 IE IE227/77A patent/IE44460B1/en unknown
- 1977-02-03 JP JP1151977A patent/JPS5297994A/en active Pending
- 1977-02-03 AU AU21931/77A patent/AU506250B2/en not_active Expired
- 1977-02-03 ES ES455625A patent/ES455625A1/en not_active Expired
- 1977-02-03 CH CH133177A patent/CH636357A5/en not_active IP Right Cessation
- 1977-02-04 NL NL7701191A patent/NL7701191A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK46677A (en) | 1977-05-16 |
| IL51339A (en) | 1980-03-31 |
| BE850942A (en) | 1977-08-01 |
| US4206120A (en) | 1980-06-03 |
| AT352875B (en) | 1979-10-10 |
| SE7701216L (en) | 1977-08-05 |
| FR2340321B1 (en) | 1980-03-07 |
| GB1529913A (en) | 1978-10-25 |
| ES455625A1 (en) | 1978-05-16 |
| ATA65177A (en) | 1979-03-15 |
| DE2704104A1 (en) | 1977-08-11 |
| FR2340321A1 (en) | 1977-09-02 |
| CH636357A5 (en) | 1983-05-31 |
| IE44460B1 (en) | 1981-12-02 |
| NL7701191A (en) | 1977-08-08 |
| AU506250B2 (en) | 1979-12-20 |
| JPS5297994A (en) | 1977-08-17 |
| IL51339A0 (en) | 1977-03-31 |
| IE44460L (en) | 1977-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL48824A0 (en) | Thc-type compounds | |
| JPS52151348A (en) | Compound | |
| JPS52125197A (en) | Transshexahydroopyridooindole compound | |
| AU2193177A (en) | Beta-lactam containing compounds | |
| JPS5317639A (en) | Hexakisazo compounds | |
| HK69883A (en) | Therapeutic compounds containing beta-lactams | |
| JPS5325537A (en) | Compound | |
| CY1178A (en) | 21-halogenopregnane compounds | |
| JPS5293772A (en) | Indolinospiropyran compound | |
| JPS5323995A (en) | Antiibacterial compound | |
| DE2965032D1 (en) | Beta-lactam compounds | |
| GB1539364A (en) | 11-deoxy-11-oxaprostaglandin compounds | |
| JPS5321222A (en) | Bissbenzoxazolyl compound | |
| JPS52156899A (en) | Compound | |
| JPS52111590A (en) | Novel cephalospoline compounds | |
| ZA772175B (en) | Oxothia compounds | |
| JPS52102227A (en) | Haloalkylphosphate compounds | |
| JPS5285216A (en) | Azamethineemetal complex compounds | |
| ZA77258B (en) | Therapeutic compounds containing beta-lactams | |
| JPS52125158A (en) | Oxothia compound | |
| JPS5297990A (en) | Cephalospoline compounds | |
| AU3796078A (en) | Beta-lactam compounds | |
| ZA77435B (en) | Beta-lactam containing compounds | |
| JPS5283790A (en) | Penicillin compounds | |
| GB1542784A (en) | Arylorganobromosilicone compounds |